# Mechanism of Allogeneic UCB Therapy in Cerebral Palsy

> **NCT03130816** · PHASE1,PHASE2 · COMPLETED · sponsor: **Bundang CHA Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Cerebral Palsy
- Child Development

## Interventions

- **BIOLOGICAL:** allogeneic cord blood transplantation

## Key facts

- **NCT ID:** NCT03130816
- **Lead sponsor:** Bundang CHA Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-29
- **Primary completion:** 2019-05-21
- **Final completion:** 2019-05-21
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2020-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03130816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03130816, "Mechanism of Allogeneic UCB Therapy in Cerebral Palsy". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03130816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*